Prognostic Value of Prothrombin Fragments 1+2 for Pulmonary Embolism Incidence

NCT01078792 · Status: UNKNOWN · Type: OBSERVATIONAL

Last updated 2010-03-02

No results posted yet for this study

Summary

To determine the possible association of prothrombin fragments 1+2 elevation with incidents of pulmonary embolism in patients with COPD exacerbation.

Conditions

  • Pulmonary Disease, Chronic Obstructive
  • Disease Exacerbation
  • Pulmonary Embolism
  • Prothrombin Fragments

Interventions

OTHER

CT pulmonary angio, blood tests

Sponsors & Collaborators

  • Hillel Yaffe Medical Center

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Israel

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01078792 on ClinicalTrials.gov